We found that MAPKAPK2 expression was predominantly enriched in IDH wild-type (wt) and 1p/19q non-codeletion glioma of which molecular subtypes predict poor prognosis of glioma patients from multiple datasets of TCGA and CGGA (Figures 1H–M). This evidence concerns the gene MAPKAPK2 and glioma.